Latest filing published 13 May 2014 for Precigen, INC., €97k.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +120.2%Entry US$17.39 · Close at T+365 US$38.31
- -16.9%Entry US$24.79 · Close at T+365 US$20.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Thomas R. Kasser: trading record in brief
Thomas R. Kasser appears in our data through filings on Precigen, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 13 August 2013 and the latest from 9 May 2014.
The open-market record is one-sided, with 2 purchases worth €157k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2014, the count stands at 1 purchase and no sales.
Most recently, on 13 May 2014, the filings show an open-market purchase worth €97k in Precigen, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas R. Kasser
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$13.39Common StockSEC:0001498902-14-000057:0Canonical exit: 7 Aug 2014 (T+90)
- 5,000 shares@ US$16.00Common StockSEC:0001498902-13-000047:0Canonical exit: 11 Nov 2013 (T+90)
2 of 2 declarations
